"When we think about solid tumors, they are primarily in epithelial locations, where immune cells cannot traffic as easily," ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Scientists at NYU’s Center for Genomics & Systems Biology have created a 3D model that could advance cancer screening and ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Once back in the body, the T-cells hunt down and eradicate the cancer cells. This method has already been very successful in some forms of leukemia. But solid tumors and especially brain tumors ...

Weill Cornell Medicine researchers have discovered a way ovarian tumors cripple immune cells: by tampering with their ability ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...